# Dianthus Therapeutics, Inc.: Form 8-K, filed Oct 16, 2025

- Company: [Dianthus Therapeutics, Inc.](/companies/dnth.md) (CIK 1690585)
- Form: 8-K
- Filed: 2025-10-16
- Accepted by EDGAR: Oct 16, 2025, 08:00 ET
- Period: 2025-10-16
- Accession: 0001193125-25-240858
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1690585/000119312525240858/dnth-20251016.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1690585/000119312525240858/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.02: Results of operations
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1690585/000119312525240858/dnth-20251016.htm

Filed Oct 16, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-240858. Last ingested by Listed: Nov 13, 2026, 16:49 ET. No prices; not investment advice.